Survey: Neurologists demonstrate inaccuracies in detecting strokes

Evan Godt | | Health Imaging | Cardiac Imaging

Up to two-thirds of neurologists inaccurately interpreted advanced imaging tests used to detect strokes in initial findings from a survey presented at the Canadian Stroke Congress in Vancouver.

Michel Shamy, MD, of the Ottawa Hospital Research Institute, presented results from an analysis of the first 374 responses (out of a planned 600) from a survey of radiologists from across North America, according to a report from The Vancouver Sun. Respondents were asked to view CT angiography and CT perfusion tests and decide whether patients were having an acute stroke and if they were suitable candidates for tPA. Read more at the link below:

Most doctors misread scans for detecting strokes

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Related Content

Global shortage of nuclear imaging isotopes may be over
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT
FDA clears AI tool that flags signs of heart disease in chest CT scans
AI-enabled plaque assessments help cardiologists ID high-risk CAD patients
Abbott CGM sensors can now be worn during common imaging procedures
New data highlight long-term benefits of HeartFlow’s AI-based CAD evaluations

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup